BioNexus Gene Lab Corp
NASDAQ:BGLC

Watchlist Manager
BioNexus Gene Lab Corp Logo
BioNexus Gene Lab Corp
NASDAQ:BGLC
Watchlist
Price: 2.67 USD -2.2% Market Closed
Market Cap: 4.8m USD

Intrinsic Value

The intrinsic value of one BGLC stock under the Base Case scenario is 5.3 USD. Compared to the current market price of 2.67 USD, BioNexus Gene Lab Corp is Undervalued by 50%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BGLC Intrinsic Value
5.3 USD
Undervaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
BioNexus Gene Lab Corp

BGLC
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BGLC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BGLC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about BioNexus Gene Lab Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioNexus Gene Lab Corp

Current Assets 7m
Cash & Short-Term Investments 2.1m
Receivables 1.5m
Other Current Assets 3.5m
Non-Current Assets 4m
Long-Term Investments 2m
PP&E 2m
Efficiency

Free Cash Flow Analysis
BioNexus Gene Lab Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioNexus Gene Lab Corp

Revenue
9.3m USD
Cost of Revenue
-8m USD
Gross Profit
1.2m USD
Operating Expenses
-2.2m USD
Operating Income
-964.4k USD
Other Expenses
21.8k USD
Net Income
-942.6k USD
Fundamental Scores

BGLC Profitability Score
Profitability Due Diligence

BioNexus Gene Lab Corp's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative 1-Year Revenue Growth
Declining ROE
Negative ROE
21/100
Profitability
Score

BioNexus Gene Lab Corp's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

BGLC Solvency Score
Solvency Due Diligence

BioNexus Gene Lab Corp's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
63/100
Solvency
Score

BioNexus Gene Lab Corp's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BGLC Price Targets Summary
BioNexus Gene Lab Corp

There are no price targets for BGLC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

BioNexus Gene Lab Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BGLC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one BGLC stock?

The intrinsic value of one BGLC stock under the Base Case scenario is 5.3 USD.

Is BGLC stock undervalued or overvalued?

Compared to the current market price of 2.67 USD, BioNexus Gene Lab Corp is Undervalued by 50%.

Back to Top